Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Telmisartan provides superior blood pressure control to valsartan and amlodipine

June 23, 2004

Enrollment complete in phase IIa trial of DG-031 for heart attack prevention

June 22, 2004

Wyeth and Karo Bio extend collaboration, advance lead compound

June 22, 2004

Trinam receives orphan medicinal product status in Europe

June 21, 2004

Promising nonprostanoid prostacyclin receptor agonist for the treatment of chronic vascular disease

June 21, 2004

Novel inotropic agent shows more potency than ouabain

June 21, 2004

Vasogen updates Celacade phase III program

June 18, 2004

FDA agrees to two pivotal protocols for pexelizumab

June 16, 2004

New Rho kinase inhibitors in early development at Bayer

June 15, 2004

Enrollment completed in Angiotech vascular wrap study

June 15, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...